<DOC>
	<DOCNO>NCT01895764</DOCNO>
	<brief_summary>The purpose study determine association methotrexate adalimumab lead decrease immunogenicity beside adalimumab alone Ankylosing Spondylitis .</brief_summary>
	<brief_title>Effect Combination Methotrexate Adalimumab Reduction Immunization Ankylosing Spondylitis ( COMARIS )</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject 18 year age old Able willing give write informed consent comply requirement study protocol Subject meet definition Ankylosing Spondylitis ( AS ) base ASAS Criteria Subject active AS , inadequate response , intolerance one nonsteroidal antiinflammatory drug Previous adalimumab treatment previous treatment one anti TNF alpha therapy . Previous methotrexate treatment , stop 3 month inclusion Surgery schedule study Female subject without method contraception Contraindication adalimumab methotrexate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>ankylose spondylitis</keyword>
</DOC>